Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 200 points on Monday. Here are some big stocks recording losses in today’s session.